Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CT’s Benefits Outweigh Risks In Some 55-And-Older Smokers, Societies Find

This article was originally published in The Gray Sheet

Executive Summary

The new recommendations are based on a meta-analysis of eight randomized trials and 13 cohort studies of low-dose computed tomography screening for lung cancer, including the large, federally funded National Lung Screening Trial.


Related Content

USPSTF Recommends Low-Dose CT Lung Cancer Screening For People At High Risk
Annual CT Screening Offers Big Mortality Benefit To Smokers – NCI





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts